According to the recent research report titled ‘Prefilled Syringes Market Size By Type, By Design, By Applications , Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025’, available with Market Study Report, global prefilled syringes market is expected to surpass a valuation of USD 9.5 billion by 2025.
 

Growing adoption of biosimilars, technological advancements, increasing cases of rheumatoid arthritis and diabetes, and rising concerns about injectables safety are the key factors driving the growth of global prefilled syringes market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2484011/
 

Notably, biosimilars are a affordable way of treating chronic disorders like cancer, and hence has been witnessing robust popularity in the recent past. However, they can be easily contaminated and therefore need protective packaging to avoid contamination. In addition, biosimilars need to be administered in specific quantities, which boost demand for pre-populated syringes, as it can be used for effective distribution of biosimilars.
 

Patients with diabetes and rheumatoid arthritis often need treatment by injection. In such cases, the prefilled syringe is an efficient, convenient, and effective alternative for medication administration. It also improves patient outcome and minimizes medication wastage, stimulating global prefilled syringes industry expansion.
 

On the downside, complexities associated with prefilled syringes are predicted to hamper the remuneration scale of the industry over the study period.
 

Based on type, plastic segment of global prefilled syringes market was valued at USD 1.3 billion in 2018 and is reckoned to witness modest gains through 2025, owing to widespread adoption of compatible plastic material for manufacturing prefilled syringe. Beneficial properties of plastic prefilled syringes such as compatibility with variety of drugs, eliminating maintenance issue, and less interference with molecular structure of biologics in preloaded syringe is contributing to the segmental growth.
 

Speaking of design type, global prefilled syringes market from dual-chamber segment is expected to record growth rate of 12.5% over 2019-2025, attributable to its extensive usage for packaging of liquid drugs and lyophilized solvent in order to obtain homogenization as well as mixing of ingredients before administration.
 

Elaborating on application spectrum, antithrombotic/thrombolytic segment of global prefilled syringes industry was worth USD 500 million in 2018 and is anticipated to register decent growth over the assessment period. Prepopulated syringes are increasingly being used for antithrombotic therapy, thereby favoring the market outlook.
 

From the regional perspective, Asia Pacific prefilled syringes industry share is expected to record a 12% growth over the estimated timeframe, owing to mounting number of patients suffering from chronic conditions such as rheumatoid arthritis, anaphylaxis, diabetes, etc. In addition, increasing government expenditure on healthcare sector will motivate industry partakers to develop innovative solutions, further contributing towards the overall market outlook.
 

Major players impacting global prefilled syringes market trends are Nipro Corporation, Gerresheimer AG, Weigao Group Co. Ltd., Mylan Laboratories Ltd., Novartis International AG, Stevanato Group, Medpro Group, Catalent Inc., (Catalent Pharma Solutions), Fresenius Kabi, OMPI Stevanato Group, SCHOTT AG, and Becton, Dickinson and Company.